Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
BMC Cancer|July 10, 2014
A comparative study of two PODXL antibodies in 840 colorectal cancer patientsTuomas Kaprio, Jaana Hagström, Christian Fermér, et al.
BMC Cancer|December 2, 2024
Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancerJefim Brodkin, Tuomas Kaprio, Jaana Hagström, et al.
Oncology|November 18, 2021
TATI, TAT-2, and CRP as Prognostic Factors in Colorectal CancerKajsa Björkman, Tuomas Kaprio, Ines Beilmann-Lehtonen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 3, 2021
CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242Kajsa Björkman, Harri Mustonen, Tuomas Kaprio, et al.
BMC Cancer|July 10, 2014
Podocalyxin is a marker of poor prognosis in colorectal cancerTuomas Kaprio, Christian Fermér, Jaana Hagström, et al.
HLA|May 29, 2021
HLA-G expression correlates with histological grade but not with prognosis in colorectal carcinomaTuomas Kaprio, Hannu Sariola, Nina Linder, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|March 25, 2022
A retrospective study of intraductal papillary neoplasia of the pancreas (IPMN) under surveillanceKatarina Johansson, Tuomas Kaprio, Heini Nieminen, et al.
Cancers|August 12, 2023
Prognostic Values of Tissue and Serum Angiogenic Growth Factors Depend on the Phenotypic Subtypes of Colorectal CancerJussi Herman Kasurinen, Jaana Hagström, Tuomas Kaprio, et al.
Plos One|February 16, 2019
Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancerTuomas Kaprio, Tiina Rasila, Jaana Hagström, et al.
Scientific Reports|November 1, 2023
The possible dual role of Ang-2 in the prognosis of pancreatic cancerMatilda Roos-Mattila, Tuomas Kaprio, Harri Mustonen, et al.
Pageof 4